Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Comment by canadapieton Nov 24, 2015 5:20pm

93 Views

Post# 24321625

RE:RE:RE:RE:RE:RE:RE:RE:Sales Update

Mr. Palinc,

i understand and can follow your counterpoints and in some way i am also disappointed the way things are going . But some points SPCEO talks about also have merit .
Are you a shareholder ? Where do you see the stock going ?
The same for SPCEO , + where is the bottom ? It must be very cheap now , isn't it ?
Thx and g l

Bullboard Posts

Day trading vs. swing trading strategies for small-cap stocks